AeroLeads people directory · profile
Erik Karrer Email & Phone Number
Character Biosciences
at
Character Biosciences
1 work email found
@clovertherapeutics.com
2 phones found area 800 and 650
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Character Biosciences
Location
San Francisco, California, United States
Company size
Who is Erik Karrer? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Erik Karrer is listed as Character Biosciences at Character Biosciences, a with 44 employees, based in San Francisco, California, United States. AeroLeads shows a work email signal at clovertherapeutics.com, phone signal with area code 800, 650, and a matched LinkedIn profile for Erik Karrer.
Erik Karrer previously worked as SVP, Drug Discovery at Character Biosciences and VP Drug Discovery at Character Biosciences. Erik Karrer holds Ph.D., Genetics from University Of California, Davis.
Company email context
Email format at Character Biosciences
This section adds company-level context without repeating Erik Karrer's masked contact details.
{first}.{last}@clovertherapeutics.com
86% confidence
AeroLeads found 1 current-domain work email signal for Erik Karrer. Compare company email patterns before reaching out.
Profile bio
About Erik Karrer
Biotech professional with 20 years drug discovery experience. Demonstrated leadership in the areas of target discovery, drug discovery research, corporate strategy, heading departments and global project teams. Technical experience in human genetics based target discovery, molecular biology, protein engineering and technology innovation. Skilled at leading target and drug discovery teams in diverse therapeutic areas (NASH, fibrosis, autoimmunity, oncology, immuno-oncology, osteoarthritis, glaucoma, asthma, cardiovascular, endometriosis, pain). Project leadership experience in NASH, fibrosis, asthma, RA and transplantation areas. Successfully led two projects to IND. Strong communication, alliance management, team building and mentoring skills.
Listed skills include Drug Discovery, Immunology, Biotechnology, Molecular Biology, and 26 others.
Current workplace
Erik Karrer's current company
Company context helps verify the profile and gives searchers a useful next step.
Character Biosciences
17 roles
Erik Karrer work experience
A career timeline built from the work history available for this profile.
Svp, Drug Discovery
Current
Dec 2022 - Present
Vp Drug Discovery
CurrentLeading human genetics-based target discovery and drug discovery research
May 2022 - Present
Vp Drug Discovery
Current
Clover Therapeutics
Mar 2020 - Present
Director, Target Discovery
-Leading evaluation of genetic and phenotypic data for identification of therapeutic drug targets and initiation of drug discovery programs
Sep 2017 - Nov 2019
Director, Drug Discovery
-Scientific management of preclinical antibody therapeutics programs-Leading evaluation of drug target opportunities and initiation of drug discovery programs-Expanding technical and operational capabilities to support program advancement and portfolio expansion
Apr 2015 - Sep 2017
Chief Scientific Officer
Ruiyi Inc.
Headed preclinical development- IL-6 antagonist antibody for treatment of RA in emerging markets - CB1 antagonist antibody for treatment of NASH/liver fibrosis and metabolic diseases (project lead) Headed discovery research- Led target evaluation and discovery of therapeutic antibodies against GPCR targets, initiated programs in pain and oncology Member of senior management team- Represented programs and technology to potential partners, investors and board of directors- Contributed to corporate strategy, advisory board and alliance management
Nov 2013 - Mar 2015
Vice President, Molecular Biology And Discovery
Astellas Pharma
• Perseid senior management team - corporate strategy, integration into global Astellas organization• Head of Discovery - managing preclinical research portfolio, leading new drug concept evaluation• Member of global development core team - providing scientific leadership to early clinical programs• Molecular Biology Dept Head - leading application and expansion of protein engineering technologies• Member of Astellas Executive Leadership Series program - global executive leadership training
Jan 2011 - Aug 2013
Senior Director, Molecular Biology And Drug Discovery
• Member of Perseid senior management team - corporate strategy, successful acquisition by Astellas• Head of Discovery - managing preclinical research portfolio, leading new drug concept evaluation• Molecular Biology Dept Head - leading application and expansion of protein engineering technologies• Project Leader, CTLA4-Ig program - led project team to filing INDs in RA and transplantation
Sep 2009 - Jan 2011
Director, Drug Discovery; Maxy-4 Project Leader
-Head of Discovery - scientific leadership to preclinical research portfolio and new product evaluation-Project Leader, CTLA4-Ig program - scientific and strategic leadership to multidisciplinary team-Represented assets to M&A candidates, ultimately co-founded Perseid Therapeutics LLC
Oct 2008 - Sep 2009
Senior Scientist
-Project Leader, next-gen CTLA4-Ig program-Represented program to potential partners, ultimately consummating co-development agreement with Astellas Pharmaceuticals
Aug 2006 - Oct 2008
Staff Scientist Iii
-Project Leader, next-gen CTLA4-Ig program-Scientific contributions to cytokine research
Dec 2003 - Aug 2006
Staff Scientist Ii
ALK-Abelló partner collaboration -Created recombinant protein vaccine candidates for the treatment of house dust mite allergies. DARPA grant - Created recombinant protein vaccine candidates to protect against bio-warfare agents.
Feb 1999 - Dec 2003
Post-Doctoral Fellow
Dr. Dennis Burton, principle investigator- Created Fab phage display libraries from the immune repertoire of HIV-positive long-term non-progressor patients.
May 1997 - Oct 1998
Post-Doctoral Fellow
NIH Research Fellowship Grant. Dr. Roger Beachy, principle investigator- Identified and cloned tobacco genes that elicit the hypersensitive response (HR).
Aug 1994 - Apr 1997
Post-Doctoral Fellow
Ceprap (A National Science Foundation Center)
Dr. Danny Alexander, principle investigator- Developed a novel method to create cDNA libraries from individual plant cells.
Aug 1992 - Aug 1994
Research Assistant
Dr. Raymond Rodriguez, principle investigator- Characterized the temporal and spatial expression of the rice and barley alpha-amylase gene families. Discovered a novel mechanism of alpha-amylase gene regulation.
Sep 1989 - Sep 1992
2 education records
Erik Karrer education
Ph.D., Genetics
University Of California, Davis
Bachelor Of Science (Bs), Genetics
University Of California, Davis
FAQ
Frequently asked questions about Erik Karrer
Quick answers generated from the profile data available on this page.
What company does Erik Karrer work for?
Erik Karrer works for Character Biosciences.
What is Erik Karrer's role at Character Biosciences?
Erik Karrer is listed as Character Biosciences at Character Biosciences.
What is Erik Karrer's email address?
AeroLeads has found 1 work email signal at @clovertherapeutics.com for Erik Karrer at Character Biosciences.
What is Erik Karrer's phone number?
AeroLeads has found 2 phone signal(s) with area code 800, 650 for Erik Karrer at Character Biosciences.
Where is Erik Karrer based?
Erik Karrer is based in San Francisco, California, United States while working with Character Biosciences.
What companies has Erik Karrer worked for?
Erik Karrer has worked for Character Biosciences, Clover Therapeutics, 23Andme, Ruiyi Inc., and Astellas Pharma.
How can I contact Erik Karrer?
You can use AeroLeads to view verified contact signals for Erik Karrer at Character Biosciences, including work email, phone, and LinkedIn data when available.
What schools did Erik Karrer attend?
Erik Karrer holds Ph.D., Genetics from University Of California, Davis.
What skills is Erik Karrer known for?
Erik Karrer is listed with skills including Drug Discovery, Immunology, Biotechnology, Molecular Biology, Protein Chemistry, Protein Engineering, Clinical Development, and Antibodies.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial